Equity to Asset ratio is calculated as total stockholders equity divided by total asset. NanoString Technologies's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-50.6 Mil. NanoString Technologies's Total Assets for the quarter that ended in Sep. 2023 was $274.7 Mil.
Therefore, NanoString Technologies's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was -0.18.
The historical rank and industry rank for NanoString Technologies's Equity-to-Asset or its related term are showing as below:
NSTGQ'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.18 Med: 0.33 Max: 0.73
Current: -0.18
During the past 13 years, the highest Equity to Asset Ratio of NanoString Technologies was 0.73. The lowest was -0.18. And the median was 0.33.
NSTGQ's Equity-to-Asset is ranked worse than 93.79% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs NSTGQ: -0.18
NanoString Technologies Equity-to-Asset Historical Data
The historical data trend for NanoString Technologies's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NanoString Technologies's Equity-to-Asset
For the Medical Instruments & Supplies subindustry, NanoString Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NanoString Technologies's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NanoString Technologies's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where NanoString Technologies's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
NanoString Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
NanoString Technologies Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of NanoString Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
NanoString Technologies (NanoString Technologies) Business Description
NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSTGQ has been successfully added to your 